Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with hereditary gastric cancer linked to a family history of hereditary breast and ovarian cancer (HBOC)

Takuma Hayashi, Kenji Sano, Mako Okada, Manabu Muto, Ikuo Konishi
doi: https://doi.org/10.1101/2024.09.03.24313047

Article Information

doi 
https://doi.org/10.1101/2024.09.03.24313047
History 
  • September 5, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Takuma Hayashi1,*,
  2. Kenji Sano2,
  3. Mako Okada1,
  4. Manabu Muto3 and
  5. Ikuo Konishi1,4
  1. 1Cancer Medicine, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Kyoto
  2. 2Pathological Division, Shinshu University Hospital, Matsumoto, 390-0877, Nagano
  3. 3Medical Oncology, Kyoto University Hospital, Kyoto 612-8555, Kyoto
  4. 4Kyoto University School of Medicine, Kyoto 606-8507, Kyoto
  1. ↵*Corresponding author:
    Takuma Hayashi, Cancer Medicine, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto 612-8555, Kyoto, e-mail: yoyoyo224{at}hotmail.com
Back to top
Posted September 05, 2024.
Download PDF

Supplementary Material

Email
Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with hereditary gastric cancer linked to a family history of hereditary breast and ovarian cancer (HBOC)
Takuma Hayashi, Kenji Sano, Mako Okada, Manabu Muto, Ikuo Konishi
medRxiv 2024.09.03.24313047; doi: https://doi.org/10.1101/2024.09.03.24313047
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area